BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 27742319)

  • 21. High-grade prostatic intraepithelial neoplasia is an independent predictor of outcome after radical prostatectomy.
    Pierorazio PM; Lambert SM; Matsukhani M; Sprenkle PC; McCann TR; Katz AE; Olsson CA; Benson MC; McKiernan JM
    BJU Int; 2007 Nov; 100(5):1066-70. PubMed ID: 17784880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is PSA density still useful in diagnosing prostate cancer?
    Pepe P; Candiano G; Fraggetta F; Galia A; Grasso G; Allegro R; Aragona F
    Arch Ital Urol Androl; 2009 Dec; 81(4):199-202. PubMed ID: 20608140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostate specific antigen findings and biopsy results following interactive ultrasound guided transperineal brachytherapy for early stage prostate carcinoma.
    Stock RG; Stone NN; DeWyngaert JK; Lavagnini P; Unger PD
    Cancer; 1996 Jun; 77(11):2386-92. PubMed ID: 8635111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Value of PSA density determination in prostate carcinoma].
    Manseck A; Benusch T; Wirth M
    Urologe A; 1997 Jul; 36(4):323-6. PubMed ID: 9340897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monofocal and plurifocal high-grade prostatic intraepithelial neoplasia on extended prostate biopsies: factors predicting cancer detection on extended repeat biopsy.
    Roscigno M; Scattoni V; Freschi M; Raber M; Colombo R; Bertini R; Montorsi F; Rigatti P
    Urology; 2004 Jun; 63(6):1105-10. PubMed ID: 15183961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The proportion of cores with high-grade prostatic intraepithelial neoplasia on extended-pattern needle biopsy is significantly associated with prostate cancer on site-directed repeat biopsy.
    Akhavan A; Keith JD; Bastacky SI; Cai C; Wang Y; Nelson JB
    BJU Int; 2007 Apr; 99(4):765-9. PubMed ID: 17378840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic inflammation is negatively associated with prostate cancer and high-grade prostatic intraepithelial neoplasia on needle biopsy.
    Karakiewicz PI; Benayoun S; Bégin LR; Duclos A; Valiquette L; McCormack M; Bénard F; Saad F; Perrotte P
    Int J Clin Pract; 2007 Mar; 61(3):425-30. PubMed ID: 17313610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostate-specific antigen in the assessment of organ donors.
    Frutos MA; Daga D; Ruiz P; Jose Mansilla J; Requena MV
    Transplant Proc; 2003 Aug; 35(5):1644-6. PubMed ID: 12962742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostate specific antigen as tumor marker: relationship with histologic grading.
    Xess A; Singh M; Raghwendra KH; Sharma HP; Shahi SK
    Indian J Pathol Microbiol; 2001 Jul; 44(3):261-4. PubMed ID: 12024909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of high grade prostatic intraepithelial neoplasia on serum total and percentage of free prostate specific antigen levels.
    Ramos CG; Carvahal GF; Mager DE; Haberer B; Catalona WJ
    J Urol; 1999 Nov; 162(5):1587-90. PubMed ID: 10524873
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Free and total serum PSA values in patients with prostatic intraepithelial neoplasia (PIN), prostate cancer and BPH. Is F/T PSA a potential probe for dormant and manifest cancer?
    Tarle M; Kraljić I
    Anticancer Res; 1997; 17(3A):1531-4. PubMed ID: 9179191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. No reason for immediate repeat sextant biopsy after negative initial sextant biopsy in men with PSA level of 4.0 ng/mL or greater (ERSPC, Rotterdam).
    Roobol MJ; van der Cruijsen IW; Schröder FH
    Urology; 2004 May; 63(5):892-7; discussion 897-9. PubMed ID: 15134973
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosis of high-grade prostatic intraepithelial neoplasia: the impact of the number of biopsy cores at initial sampling on cancer detection after a saturation re-biopsy.
    Roscigno M; Scattoni V; Freschi M; Raber M; Angiolilli D; Galosi A; Lacetera V; Montironi R; Muzzonigro G; Deho F; Feroldi L; Deiana G; Chinaglia D; Montorsi F; Da Pozzo LF
    Arch Ital Urol Androl; 2010 Dec; 82(4):242-7. PubMed ID: 21341572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostate Cancer in Deceased Liver Donors.
    Skalski M; Gierej B; Ziarkiewicz-Wróblewska B; Hołówko W; Krawczyk M
    Transplant Proc; 2016 Jun; 48(5):1378-80. PubMed ID: 27496409
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcome for repeated biopsy of the prostate: roles of serum PSA, small atypical glands, and prostatic intraepithelial neoplasia.
    Brimo F; Vollmer RT; Corcos J; Humphrey PA; Bismar TA
    Am J Clin Pathol; 2007 Oct; 128(4):648-51. PubMed ID: 17875517
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of prostate cancer gene 3 score, prostate health index and percentage free prostate-specific antigen for differentiating histological inflammation from prostate cancer and other non-neoplastic alterations of the prostate at initial biopsy.
    De Luca S; Passera R; Bollito E; Manfredi M; Scarpa RM; Sottile A; Randone DF; Porpiglia F
    Anticancer Res; 2014 Dec; 34(12):7159-65. PubMed ID: 25503144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of free-to-total prostate specific antigen (F/T PSA), prostate specific antigen density (PSAD) and (F/T)/PSAD sensitivity on reduction of unnecessary prostate biopsies for patients with PSA in gray zone.
    Milkovic B; Dzamic Z; Pejcic T; Kajmakovic B; Nikolic D; Cirovic D; Knezevic T; Dzamic D; Hadzi-Djokic J
    Ann Ital Chir; 2014; 85(5):448-53. PubMed ID: 25599711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of ERG protein, a prostate cancer specific marker, in high grade prostatic intraepithelial neoplasia (HGPIN): lack of utility to stratify cancer risks associated with HGPIN.
    He H; Osunkoya AO; Carver P; Falzarano S; Klein E; Magi-Galluzzi C; Zhou M
    BJU Int; 2012 Dec; 110(11 Pt B):E751-5. PubMed ID: 23046279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Status of PSA determination for early detection of prostate carcinoma].
    Hammerer P; Huland H
    Versicherungsmedizin; 1995 Jun; 47(3):83-6. PubMed ID: 7541925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reflex PCA3 messenger ribonucleic acid testing: validation of postbiopsy urine samples and correlation with prostate biopsy findings in ∼2000 patients.
    Brown JG; Fulmer JR; Romano J; Pownell J; Rigler W; Wirtshafter A; Sarno M; Shappell SB
    Urology; 2014 Nov; 84(5):1172-80. PubMed ID: 25443926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.